CaliPharms Inc is a developmental stage acquisition company. The Company is focused on acquiring, merging, and joint venturing with legally permitted fully operational marijuana-cannabis businesses. The Company is seeking acquisitions in medical marijuana-cannabis cultivation. The Company focuses on the medical-grade marijuana-cannabis within the State of California. The Company is also expanding into other sectors that support the legalized marijuana industry.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
26-09-18	US$0.000001	0.00%	100,000

Delayed Quote OTC Markets

More quotes

Market Closed - OTC Markets 09:30:00 2026-09-18 EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	-

18-11-13	CaliPharms, Inc. Launches a New CBD Muscle & Joint Relief Roll On Gel	CI
18-08-30	Joe Pavlik Joins the Advisory Board of CaliPharms, Inc	CI

Market Cap	401K 350K 330K 300K 562K 38.51M 565K 3.96M 1.53M 19.58M 1.51M 1.47M 62.99M	P/E 2012 *	-	P/E 2013	-0.51x
Enterprise Value	1.07M 931K 879K 798K 1.5M 102M 1.5M 10.53M 4.06M 52.1M 4.01M 3.92M 168M	EV / Sales 2012 *	-	EV / Sales 2013	-
Free-Float	100%	Yield 2012 *	-	Yield 2013	-

18-11-13	CaliPharms, Inc. Launches a New CBD Muscle & Joint Relief Roll On Gel	CI
18-08-30	Joe Pavlik Joins the Advisory Board of CaliPharms, Inc	CI
18-08-14	Calipharms Announces Beverage Master Distributor Agreement with One Elite Sports	CI
18-01-11	CaliPharms Mulls Acquisitions	CI
17-12-26	Bayport International Holdings, Inc. Engages CaliPharms, Inc. to Expand CBD Product Offering for Weedwiser e-commerce Platform	CI
17-07-13	CaliPharms Mulls Acquisitions	CI
17-04-17	CaliPharms Enters Acquisition Discussions With United Cannabis	CI
17-03-28	CaliPharms, Inc. completed the acquisition of 51% stake in Pacific Cannabis Growers, Inc.	CI
17-03-16	CaliPharms, Inc. signed a non-binding term sheet to acquire 51% stake in Pacific Cannabis Growers, Inc.	CI
17-02-06	Kleangas Energy Technologies, Inc. completed the acquisition of 51% stake in Country Junction Farms.	CI
17-01-09	Kleangas Energy Technologies, Inc. signed a terms sheet to acquire Country Junction Farms for $3.4 million.	CI
16-12-26	Kleangas Energy Seeks Acquisitions	CI
15-07-22	Kleangas Energy Technologies, Inc cancelled the acquisition of Company, Inc. (“CI”) from Jerry Hansen, Tracy Johnson and The PI Foundation.	CI

18-11-15	CaliPharms Debuts New CBD Muscle & Joint Relief Product at Marijuana Business Conference in Las Vegas	GL
18-09-19	CaliPharms has Embarked on the Research and Development of its Initial Series of Naturally Derived CBD (Cannabidiol) Products	GL
18-08-30	Celebrity Fitness Expert & Formulator Joe Pavlik Joins the CaliPharms Advisory Board	GL
18-08-23	CaliPharms Enters Discussions With THC Beverage Company and CBD Producer	GL
18-08-14	CaliPharms And Beverage Master Distributor Sign LOI	GL

CaliPharms, Inc. Stock

Stocks

KGET

US4984561021

Pharmaceuticals

Valuation: CaliPharms, Inc.

Chart: CaliPharms, Inc.

Latest news: CaliPharms, Inc.

Press Releases: CaliPharms, Inc.

Price Extremes

Alternative Medicine

Financials

Company Profile

Quotes

1 week	0		0
1 month	0		0
Current year	0		0
1 year	0		0
3 years	0		0
5 years	0		0
10 years	0		0.01

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CALIPHARMS, INC.	0.00%	0.00%	-	-	13.88K
YUNNAN BAIYAO GROUP CO.,LTD	-0.66%	+1.29%	-12.71%	-5.43%	13.59B
BEIJING TONGRENTANG CO., LTD	0.00%	-0.77%	-33.26%	-56.94%	4.75B
DONG-E-E-JIAO CO., LTD.	-0.68%	-1.27%	-5.37%	-7.37%	4.31B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	+0.53%	+0.07%	-7.65%	-32.11%	3.79B
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	+0.16%	+1.57%	-1.06%	-4.58%	3.46B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+1.38%	-0.06%	-21.64%	-0.06%	3.44B
TASLY PHARMACEUTICAL GROUP CO., LTD	-0.57%	-1.14%	-11.32%	-1.42%	3.09B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-0.62%	+0.48%	-22.17%	-18.74%	2.25B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.52%	+0.16%	-27.89%	-22.98%	1.64B
Average	+0.01%	-0.75%	-15.90%	-16.63%	4.03B
Weighted average by Cap.	-0.17%	-0.59%	-14.67%	-14.83%

	2012	2013
Net sales	-	-
Net income	-917K -800K -755K -686K -1.28M -87.98M -1.29M -9.04M -3.49M -44.73M -3.44M -3.37M -144M	-216K -189K -178K -162K -303K -20.77M -305K -2.14M -824K -10.56M -813K -795K -33.98M
Net Debt	617K 538K 508K 461K 864K 59.17M 867K 6.08M 2.35M 30.08M 2.32M 2.27M 96.8M	667K 581K 549K 498K 934K 63.97M 938K 6.58M 2.54M 32.52M 2.5M 2.45M 105M